SCHEMBL4975236

SCHEMBL4975236

CCCCOC(=O)N1CCCC(C(OCC(=O)NCC)c2cccc(Cl)c2)C1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
REN P00797 18/20 0.51
CYP3A4 P08684 3/20 0.49
ADRB3 P13945 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073475 0.88 REN (0.52) RENCYP3A4ADRB3
SCHEMBL4972304 0.88 REN (0.52) RENCYP3A4ADRB3
SCHEMBL3609018 0.87 REN (0.51) RENCYP3A4
SCHEMBL3609019 0.87 REN (0.51) RENCYP3A4
SCHEMBL4968724 0.86 REN (0.56) RENCYP3A4
SCHEMBL4968733 0.86 REN (0.56) RENCYP3A4
SCHEMBL14856640 0.86 REN (0.66) RENCYP3A4
SCHEMBL14856641 0.86 REN (0.66) RENCYP3A4
SCHEMBL4972326 0.84 REN (0.51) RENCYP3A4
SCHEMBL4972319 0.84 REN (0.51) RENCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed